Spark to charge $850,000 per patient for blindness gene therapy
(Reuters) - Spark Therapeutics Inc said on Wednesday it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a lower than expected price that the company said reflects patient and insurer concerns about access and cost.
from Reuters: Health News http://reut.rs/2Ck6Ubo
http://bit.ly/2zwRqiM